Title: Alasdair Reid
1Global Progress in Implementing Collaborative
TB/HIV Activities Comparison with the 15
PEPFAR Focus Countries
2Outline
- Background
- Methods
- Results
- Conclusion
3 Over 26 million TB patients treated under
DOTS worldwide
WHO target
60
53
45
37
32
CASE DETECTION ()
28
24
22
18
16
94 95 96 97 98 99 01
02 03 04 05
4Global TB control report questionnaire
- Sent to all member states
- Included questions on TB/HIV for last 3 years
- 63 countries with highest burden of HIV related
TB sent detailed questions on TB/HIV activities - Responses of PEPFAR focus countries compared with
the others
5 6Collaborative TB/HIV activities
7Overall results from Global TB Control Report
2007
- Only 7 of all TB patients were tested for HIV in
2005 (10 in Africa) - Less than 0.5 of all PLHIV were reported to have
been screened for TB in 2005
8PEPFAR countries testing more TB patients
9Outcome of testing TB patients for HIV2005 data
- HIV testing for TB patients
- In 13 PEPFAR Countries 49 had HIV
- In 25 Non PEPFAR Countries 13 had HIV
-
- Of those found to be HIV positive
-
- Placed on CPT 78 in PEPFAR (5)
- 57 in Non
PEPFAR (14) -
- Placed on ART 26 in PEPFAR (6)
- 44 in Non
PEPFAR (14) -
10PEPFAR countries detecting more
11PEPFAR countries more CPT
12Antiretroviral therapy
13PEPFAR countries more ART
14PEPFAR few countries report on TB screening
15But many TB cases detected through screening
16Outcome of TB screening for PLHIV2005 data
- PEPFAR 33 of screened had TB
- (2 countries South Africa 38. Zambia 14)
- Non - PEPFAR 4 of screened had TB
- (8 countries range 3 to 20)
- Overall in 10 countries reporting 12
17Few PLHIV accessing IPT
18Conclusions
- Effective interventions
- Implementation increasing over time
- Implementation generally better in PEPFAR focus
countries
19Conclusions
- BUT, many opportunities to provide better care
and avoid unnecessary deaths are being missed - Poor uptake of TB screening (for case finding
infection control) and IPT - ME improving but many countries still not
reporting
20Conclusions
- Need to strengthen political commitment to TB/HIV
collaboration - TB infection control in HIV care
- Engaging communities in designing, advocating
for, implementing and monitoring the
collaborative response - Urgent need for new tools to prevent, diagnose,
and treat TB in PLHIV
21Acknowledgements
- NTP/NACP managers
- WHO country and regional offices
- WHO THD
- Christian Gunneberg
- WHO TME
- Mehran Hosseini
- Brian Williams